European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure

• Published in: Journal of headache and pain Vol. 23; no. 1; pp. 133 - 10
• Main Authors: Sacco, Simona, Lampl, Christian, Amin, Faisal Mohammad, Braschinsky, Mark, Deligianni, Christina, Uludüz, Derya, Versijpt, Jan, Ducros, Anne, Gil-Gouveia, Raquel, Katsarava, Zaza, Martelletti, Paolo, Ornello, Raffaele, Raffaelli, Bianca, Boucherie, Deirdre M., Pozo-Rosich, Patricia, Sanchez-del-Rio, Margarita, Sinclair, Alexandra, Maassen van den Brink, Antoinette, Reuter, Uwe
• Format: Journal Article
• Language: English
• Published: Milan Springer Milan 12.10.2022; Springer Nature B.V; SpringerOpen; BMC
• Subjects: Attack; Clinical medicine; Consensus; Consensus Article; Ditan; Drug resistance; Gepant; Headache; Headaches; Internal Medicine; Life Sciences; Literature reviews; Medication; Medicine; Medicine & Public Health; Migraine; Neurobiology; Neurology; Neurons and Cognition; Pain management; Pain Medicine; Patients; Pharmaceutical sciences; Triptan; Well being; Headache; Ditan; Migraine; NSAIDs; Attack; Triptan; Gepant

Background Triptans are migraine-specific acute treatments. A well-accepted definition of triptan failure is needed in clinical practice and for research. The primary aim of the present Consensus was to provide a definition of triptan failure. To develop this definition, we deemed necessary to devel...